Skip to main content
Premium Trial:

Request an Annual Quote

New Product Watch: May 18, 2010


Fluidigm this week launched its FC1 Cycler. The firm said the thermo cycler will reduce the thermal cycling time by a factor of three when compared with its current products, and will reduce system configuration costs for customers conducting high sample throughput SNP genotyping since they will need fewer thermal cyclers to achieve their output requirements.

According to Fluidigm, the cycler is compatible with its 96.96 and 48.48 Dynamic Array integrated fluidic circuits, and its 12.765 Digital Array IFC. The FC1 Cycler, combined with the company's EP1 Reader or BioMark real-time PCR system, can complete the entire workflow of the system in a matter of hours with only minutes of hands-on time for loading the chips, Fluidigm said. It previously took customers days of hands-on time and weeks of effort to complete this volume of work using traditional 384-well plates, the firm added.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more